loading page

The 2024 outbreak of Parvovirus B19 as a global obstetrical threat. Insights from an Obstetrics Referral Center in Northern Italy
  • +5
  • Beatrice TASSIS,
  • Lea TESTA,
  • Fulvia PAMPO,
  • Simona BOITO,
  • Giulia TISO,
  • Veronica ACCURTI,
  • Irene Cetin,
  • Nicola PERSICO
Beatrice TASSIS
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center

Corresponding Author:beatrice.tassis@policlinico.mi.it

Author Profile
Lea TESTA
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Fulvia PAMPO
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Simona BOITO
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Giulia TISO
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Veronica ACCURTI
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Irene Cetin
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile
Nicola PERSICO
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli Center
Author Profile

Abstract

Objective: A significant increase in Parvovirus B 19 (B19V) infections has been reported in the last months in some European countries. This outbreak could be highly detrimental for pregnant women, considering the capacity of the virus to harm the fetus. However, the magnitude and spread of this outbreak is yet unclear. There is the need for more evidence from other areas and focusing on pregnancy. Methods: Pregnant women with B19V infection who were managed in a referral hospital located in Milan, Northern Italy were reviewed. The primary aim was recording the frequency of ascertained cases of B19V infection in the period January-July 2024 and comparing these data to the frequencies recorded in the previous 9 years (2015-2023). The secondary aim of the study was comparing the severity of the infections in these two periods. Results: The number of B19V infections markedly increased in the first 7 months of 2024. Until 2023, the number of cases per year were below 7, with no cases reported in 2020-2022, while in the period January-July 2024, the number raised to 59 (p<0.001). Maternal characteristics and fetal outcomes before and after January 2024 did not differ. Conclusions: Italy is also involved in the ongoing outbreak of B19V infection and pregnant women are exposed to this threat. Public health authorities must promptly engage to monitor the situation and consider the possibility to introduce universal screening and global preventive measures, at least up to the end of the surge.
24 Aug 2024Submitted to Journal of Medical Virology
26 Aug 2024Submission Checks Completed
26 Aug 2024Assigned to Editor
26 Aug 2024Review(s) Completed, Editorial Evaluation Pending
27 Aug 2024Reviewer(s) Assigned
10 Sep 2024Editorial Decision: Revise Major
15 Oct 20241st Revision Received
18 Oct 2024Submission Checks Completed
18 Oct 2024Assigned to Editor
18 Oct 2024Review(s) Completed, Editorial Evaluation Pending
18 Oct 2024Reviewer(s) Assigned
22 Oct 2024Editorial Decision: Accept